Gutwerg Ori 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Gutwerg Ori
SVP, GENERICS
Transactions
- Exercise/Conversion
Common Stock
2025-03-05$31.49/sh+300$9,447→ 99,476 total - Sale
Common Stock
2025-03-05$60.03/sh−300$18,009→ 99,176 total - Sale
Common Stock
2025-03-05$60.00/sh−5,084$305,040→ 94,092 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-05$31.49/sh−300$9,447→ 13,204 totalExercise: $31.49Exp: 2031-02-15→ Common Stock (300 underlying)
Footnotes (2)
- [F1]The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price.
- [F2]25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025.